Found 109 matching trials
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself. N/A A retrospective study of de-identified (to preserve patient privacy) patien...
Show More Learn More & Join Trial
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis PHASE2 This phase II trial studies how well radiation therapy given with standard ...
Show More Location
Grady Health System
Learn More & Join Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer PHASE2 This phase II trial studies the side effects and how well palbociclib and l...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer PHASE3 This study is a prospective, open-label, multicenter, randomized controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of PF-07248144 in Advanced or Metastatic Solid Tumors PHASE2 This is an open-label, multi center study to evaluate safety, tolerability,...
Show More Learn More & Join Trial
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer PHASE4 A study of palbociclib in combination with letrozole as treatment of post-m...
Show More Location
Benjamin Carl Forster
Learn More & Join Trial
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer PHASE3 POLAR is a phase III clinical trial, which will test the safety and efficac...
Show More Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Learn More & Join Trial
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer PHASE3 Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Show More Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Learn More & Join Trial
SMMART Adaptive Clinical Treatment (ACT) Trial EARLY_PHASE1 SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Show More Location
Multiple Locations
Learn More & Join Trial